UPDATE: Tecogen Announces First Quarter 2018 Results With

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
44
UPDATE: Tecogen Announces First Quarter 2018 Results

With Another Positive Quarter and Financial Resources, Tecogen is Primed for Growth

WALTHAM, Mass., May 15, 2018 (GLOBE NEWSWIRE) -- Tecogen ® Inc. (NASDAQ: TGEN ), a leading manufacturer of clean energy products which, through patented technology, nearly eliminate criteria pollutants and significantly reduce a customer's carbon footprint, reported revenues of $10,175,427 for the quarter ended March 31, 2018 compared to $6,846,767 for the same period in 2017, or 48.6% growth in top line revenue. The energy production revenue from the sites of our wholly-owned subsidiary, American DG Energy, added $1,782,535 in revenue to the quarterly result. Consolidated gross profit for the first quarter of 2018 was $3,837,803 compared to $2,914,673 in the first quarter of 2017, an increase of 31.7%, or $923,130, in gross profit year over year.

Adjusted non-GAAP EBITDA (1) , excluding the unrealized loss on EuroSite Power Inc.'s shares owned by American DG Energy and merger related expenses, was a positive $303,757 for the first quarter of 2018 versus $190,825 for the first quarter of 2017, an increase of $112,932, or 59.2%. (Adjusted EBITDA is defined as net income attributable to Tecogen, adjusted for interest, depreciation and amortization, stock-based compensation expense, unrealized loss on equity securities and merger related expenses. See table following the statements of operations for a reconciliation from net income to Adjusted EBITDA as well as important disclosures about the company's use of Adjusted EBITDA).

Depreciation and amortization jumped to $199,181 for the first quarter of 2018 from $64,281 for the same period in the prior year. The increase is related to the depreciation of American DG Energy's energy producing equipment net of the amortization of the corresponding contracts.

The Company is investing in research and development, as discussed in the "Emissions Technology" section below resulting in an increase in research and development expenses of 67.3% to $302,230.

Income from operations was $70,906 compared to $77,702 in the prior year comparable period in spite of the increased depreciation and amortization of $134,900 discussed above. Similarly, Tecogen delivered net income for the quarter of $20,759 compared to $44,787 for the first quarter 2017. The quarter's results included an unrealized loss on EuroSite Power's common stock of $19,681 (previously presented in "Other Comprehensive Loss") and non-recurring expenses totaling $9,610 related to the company's merger with American DG Energy.

Tecogen's Chief Executive Officer Benjamin Locke noted, "Coming off a full year of profitability in 2017, our first quarter results are tremendously positive as we look forward to maintaining success in 2018. With the addition of a $10 million revolving line of credit, the Company now has access to funds that will allow us to focus on growth, including our research and development efforts, expansion into new markets for our products, and give us the ability to take on larger projects."

Revenue results were driven by solid growth in product and services related revenues as well as the addition of energy production revenues provided by American DG Energy.  Total services related revenues for the first quarter of 2018 grew 16.8% over the prior year period, driven primarily by installation activity, while product revenue increased by 30.9% compared to the first quarter of 2017. Chiller sales grew by 273.8%, partially offset by a 23.2% decline in cogeneration sales from the year-ago period.

Gross margin for the quarter was 37.7% compared to 42.6% in the first quarter of 2017, well within management's targeted 35-40% gross margin range.

On a combined basis, operating expenses increased to $3,766,897 for the first quarter 2018 from $2,836,971 in the same quarter of 2017. An increase in research and development expenses of 67.3% to $302,230, and selling expenses, which rose 50.9% to $675,118, and the consolidation of American DG Energy's core overhead accounted for the increase. The increase in selling expenses was due to an increase in marketing related activity and higher sales commissions.

Backlog of products and installations was $14.6 million as of first quarter end, and stood at $16.6 million as of May 14, 2018.

Major Highlights:

Financial

  • Consolidated gross profit for the first quarter of 2018 was $3,837,803 compared to $2,914,673 in the first quarter of 2017, an increase of 31.7%, or $923,130, in gross profit year over year.

  • On a combined basis, operating expenses rose to $3,766,897 for the first quarter of 2018 from $2,836,971 in the first quarter of 2017. The consolidation of American DG Energy's operations, an increase in research and development expenses of $121,616 and an increase in selling expenses to $675,118 from $447,452 accounted for the year-over-year increase.

  • Excluding non-recurring merger related costs and stock compensation expense, adjusted non-GAAP EBITDA (1) was $303,757 for the quarter compared to $190,825 for the first quarter of 2017.

  • Net income attributable to Tecogen for the three months ended March 31, 2018 was $20,759 compared to $44,787 for the same period in 2017. As discussed above, net income includes an unrealized loss of $19,681 due to market fluctuations in the EuroSite Power common stock owned by American DG Energy due to the implementation of a recent accounting standard change adopted by Tecogen in Q1 2018. Prior to this accounting change, unrealized gains and losses on this investment were accounted for as "other comprehensive income (loss)", falling below the net income line.

  • Net income per share was $0.00 for the three months ended March 31, 2018 and 2017.

  • On May 4, 2018, the Company and its wholly-owned subsidiaries, American DG Energy  and TTcogen LLC, entered into a Credit Agreement with Webster Business Credit Corporation, providing the Company with a line of credit up to $10 million on a revolving secured basis, with availability based on certain accounts receivable and inventory balances.

  • Current assets at quarter end of $23,704,894 were more than double current liabilities of $10,965,253. Current liabilities for the three months ended March 31, 2018 included $850,000 of short-term debt due to a related party that Tecogen assumed with the acquisition of American DG Energy, and repaid in full on May 4, 2018 upon the closing of the $10 million revolving line of credit.

Sales & Operations

  • Product revenues increased 30.9% from the same period in 2017. Cogeneration sales have pulled back 23.2% after last year's surge, although they remain well above sales levels prior to InVerde's upgrade. In contrast, chiller sales increased 273.8% year over year. Increasing interest from both the indoor agriculture market and the growing recognition of the value proposition of "mechanical CHP" continue to be the key drivers.

  • Services revenues grew 16.8% year-on-year, benefiting from increasing penetration in service contracts and favorable operating metrics for the installed fleet. Continued penetration of our 'turnkey lite' offering, which includes custom value-added engineering design work as well as custom factory engineered accessories and load modules, has been a good source of services revenue growth and is expected to continue to develop as an important revenue stream. 

  • Current sales backlog of equipment and installations as of Monday, May 14, 2018 was $16.6 million, driven by strong traction in the InVerde and Tecochill product lines and installation services.  As of March 31, 2018 the backlog was $14.6 million compared to $13.6 million as of March 31, 2017, showing a sustainable backlog at this level.

  • Indoor agriculture continues to be a rapidly emerging new opportunity for growth, particularly for the Tecochill line of natural gas powered chillers. Interest for our products from new growers entering the market remains strong.

  • On March 27, 2018, Tecogen completed the purchase of the 50% interest of TTcogen LLC owned by Tedom a.s. for $72.6 thousand. The purchase provides Tecogen with full ownership of all TTcogen in-process contracts as well as the exclusive right to market, sell and distribute Tedom's T35 combined heat and power equipment within an agreed upon territory. Tecogen will continue to provide services for Tedom equipment sold by TTcogen or Tecogen.

Emissions Technology

  • Our development program with the Propane Education and Research Council (PERC) to demonstrate the viability of our emissions technology in fork trucks is nearing conclusion with highly positive results. Results have conclusively shown that the Ultera process is highly effective in improving the emissions output from the standard fork truck and shows a clear path to its certification as a “near-zero” emitting fork truck under California regulations. Executives from the manufacturer and PERC are planning to visit Tecogen on May 23 to view the prototype design and operation first hand.

  • In the area of mobile, gasoline applications of Ultera, our development work continues under company funding subcontracted to a highly-respected, independent institute that specializes in powertrain research. They are approximately midway through the funded initial phase which is focused on optimizing our catalyst formulations.

  • This month, the company has been notified by the European Patent Office of its intent to grant a patent for Tecogen’s Ultera emissions technology. This patent will give Tecogen exclusive control over the Ultera technology in markets in Europe which are markets where Tecogen hopes to commercialize the Ultera technology. This patent supplements Tecogen’s portfolio of Ultera technology patents.

Commenting on the fork truck project, Tecogen's President and Chief Operating Officer, Robert Panora, stated, "The fork truck demonstration program is ending on a very positive note. The impressive test results, while expected, are nevertheless compelling while simultaneously addressing a significant market need for all stakeholders, including propane suppliers, OEM’s, and operators who often prefer lower cost and extended operation of propane units to the electric alternative."

Conference Call Scheduled for Today at 11:00 am ET
Tecogen will host a conference call today to discuss the third quarter results beginning at 11:00 am eastern time.  To listen to the call dial (877) 407-7186 within the U.S. and Canada, or (201) 689-8052 from other international locations .  Participants should ask to be joined to the Tecogen first quarter 2018 earnings call.  Please begin dialing 10 minutes before the scheduled starting time.  The earnings press release will be available on the Company website at www.Tecogen.com in the "News and Events" section under "About Us." The earnings conference call will be webcast live. To view the associated slides, register for and listen to the webcast, go to http://investors.tecogen.com/webcast.  Following the call, the webcast will be archived for 30 days.

The earnings conference call will be recorded and available for playback one hour after the end of the call through Thursday June 14, 2018.  To listen to the playback, dial (877) 660-6853 within the U.S. and Canada , or (201) 612-7415 from other international locations and use Conference Call ID#: 13679190.

About Tecogen

Tecogen Inc. designs, manufactures, sells, installs, and maintains high efficiency, ultra-clean, cogeneration products including natural gas engine-driven combined heat and power, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational and industrial use. The company is known for cost efficient, environmentally friendly and reliable products for energy production that, through patented technology, nearly eliminate criteria pollutants and significantly reduce a customer’s carbon footprint.

In business for over 35 years, Tecogen has shipped more than 3,000 units, supported by an established network of engineering, sales, and service personnel across the United States. For more information, please visit www.tecogen.com or contact us for a free Site Assessment.

Tecogen, InVerde e+, Ilios, Tecochill, and Ultera are registered trademarks or pending trademark registrations of Tecogen Inc.

Forward Looking Statements

This press release and any accompanying documents, contain “forward-looking statements” which may describe strategies, goals, outlooks or other non-historical matters, or projected revenues, income, returns or other financial measures, that may include words such as "believe," "expect," "anticipate," "intend," "plan,"  "estimate," "project," "target," "potential," "will," "should," "could," "likely," or "may" and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update or revise any forward-looking statements.

In addition to those factors described in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q under “Risk Factors”, among the factors that could cause actual results to differ materially from past and projected future results are the following: fluctuations in demand for our products and services, competing technological developments, issues relating to research and development, the availability of incentives, rebates, and tax benefits relating to our products and services, changes in the regulatory environment relating to our products and services, integration of acquired business operations, and the ability to obtain financing on favorable terms to fund existing operations and anticipated growth.

In addition to GAAP financial measures, this press release includes certain non-GAAP financial measures, including adjusted EBITDA which excludes certain expenses as described in the presentation.  We use Adjusted EBITDA as an internal measure of business operating performance and believe that the presentation of non-GAAP financial measures provides a meaningful perspective of the underlying operating performance of our current business and enables investors to better understand and evaluate our historical and prospective operating performance by eliminating items that vary from period to period without correlation to our core operating performance and highlights trends in our business that may not otherwise be apparent when relying solely on GAAP financial measures.

Tecogen Media & Investor Relations Contact Information: 

Benjamin Locke
P: 781-466-6402
E: Benjamin.Locke@tecogen.com

John N. Hatsopoulos
P: 781-622-1120
E: John.Hatsopoulos@tecogen.com

 
TECOGEN INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited)
       
  March 31, 2018   December 31, 2017
ASSETS      
Current assets:      
Cash and cash equivalents $ 1,202,334     $ 1,673,072  
Accounts receivable, net 11,790,537     9,536,673  
Unbilled revenue 4,745,320     3,963,133  
Inventory, net 5,096,023     5,130,805  
Due from related party —     585,492  
Prepaid and other current assets 870,680     771,526  
Total current assets 23,704,894     21,660,701  
Property, plant and equipment, net 12,048,483     12,265,711  
Intangible assets, net 2,948,359     2,896,458  
Goodwill 13,365,655     13,365,655  
Other assets 462,870     482,551  
TOTAL ASSETS $ 52,530,261     $ 50,671,076  
       
LIABILITIES AND STOCKHOLDERS’ EQUITY      
Current liabilities:      
Accounts payable $ 6,835,299     $ 5,095,285  
Accrued expenses 1,705,890     1,416,976  
Deferred revenue 1,509,224     1,293,638  
Loan due to related party 850,000     850,000  
Interest payable, related party 64,840     52,265  
Total current liabilities 10,965,253     8,708,164  
Long-term liabilities:      
Deferred revenue, net of current portion 303,002     538,100  
Unfavorable contract liability, net 7,464,950     7,729,667  
Total liabilities 18,733,205     16,975,931  
Commitments and contingencies (Note 9)      
       
Stockholders’ equity:      
Tecogen Inc. stockholders’ equity:      
Common stock, $0.001 par value; 100,000,000 shares authorized;
24,807,096 and 24,766,892 issued and outstanding at March 31,
2018 and December 31, 2017, respectively
24,807     24,767  
Additional paid-in capital 56,264,398     56,176,330  
Accumulated other comprehensive loss-investment securities —     (165,317 )
Accumulated deficit (22,940,803 )   (22,796,246 )
Total Tecogen Inc. stockholders’ equity 33,348,402     33,239,534  
Noncontrolling interest 448,654     455,611  
Total stockholders’ equity 33,797,056     33,695,145  
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 52,530,261     $ 50,671,076  


 
TECOGEN INC.  
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
   
  Three Months Ended
  March 31,
2018
  March 31,
2017
Revenues              
Products $ 3,673,506     $ 2,807,347  
Services 4,719,386     4,039,420  
Energy production 1,782,535     —  
Total revenues 10,175,427     6,846,767  
Cost of sales      
Products 2,409,115     1,756,849  
Services 2,782,854     2,175,245  
Energy production 1,145,655     —  
Total cost of sales 6,337,624     3,932,094  
Gross profit 3,837,803     2,914,673  
Operating expenses      
General and administrative 2,789,549     2,208,905  
Selling 675,118     447,452  
Research and development 302,230     180,614  
Total operating expenses 3,766,897     2,836,971  
Income from operations 70,906     77,702  
Other expense      
Interest income and other expense, net (1,072 )   (1,213 )
Interest expense (13,013 )   (31,702 )
Unrealized loss on investment securities (19,681 )   —  
Total other expense, net (33,766 )   (32,915 )
Consolidated net income 37,140     44,787  
Income attributable to the noncontrolling interest (16,381 )   —  
Net income attributable to Tecogen Inc. $ 20,759     $ 44,787  
       
Net income per share - basic $ 0.00     $ 0.00  
Net income per share - diluted $ 0.00     $ 0.00  
Weighted average shares outstanding - basic 24,803,527     20,037,795  
Weighted average shares outstanding - diluted 24,881,185     20,317,142  


Non-GAAP financial disclosure (1)      
Net income attributable to Tecogen Inc. $ 20,784     $ 44,787  
Interest & other expense, net 14,085     32,915  
Depreciation & amortization, net 199,181     64,281  
EBITDA 234,050     141,983  
Stock based compensation 40,416     48,842  
Unrealized loss on shares of EUSP 19,681     —  
Merger related expenses 9,610     —  
Adjusted EBITDA $ 303,757     $ 190,825  


 
TECOGEN INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
   
  Three Months Ended
  March 31,
2018
  March 31,
2017
CASH FLOWS FROM OPERATING ACTIVITIES:              
Consolidated net income $ 37,140     $ 44,787  
Adjustments to reconcile net income to net cash used in operating activities:      
Depreciation, accretion and amortization, net 199,181     64,281  
Provision (recovery) of inventory reserve 1,000     (36,000 )
Stock-based compensation 40,416     48,842  
Non-cash interest expense —     203  
Loss on sale of assets 4,120     2,909  
Provision for losses on accounts receivable 4,600     —  
Changes in operating assets and liabilities, net of effects of acquisitions      
(Increase) decrease in:      
Accounts receivable (1,496,737 )   (471,660 )
Unbilled revenue (549,647 )   (77,410 )
Inventory, net 33,782     (1,265,013 )
Due from related party —     (75,705 )
Prepaid expenses and other current assets (99,153 )   (199,561 )
Other non-current assets 19,681     (69,875 )
Increase (decrease) in:      
Accounts payable 855,949     644,323  
Accrued expenses and other current liabilities 288,913     (224,394 )
Deferred revenue (64,122 )   61,364  
Interest payable, related party 12,575     —  
Net cash used in operating activities (712,302 )   (1,552,909 )
CASH FLOWS FROM INVESTING ACTIVITIES:      
Purchases of property and equipment (145,326 )   (73,330 )
Proceeds from sale of assets 3,606     —  
Purchases of intangible assets (83,856 )   (53,608 )
Cash acquired in asset acquisition 442,786     —  
Expenses associated with asset acquisition (553 )   —  
Distributions to noncontrolling interest (23,338 )   —  
Net cash provided by (used in) investing activities 193,319     (126,938 )
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from the exercise of stock options 48,245     106,835  
Net cash provided by financing activities 48,245     106,835  
Change in cash and cash equivalents (470,738 )   (1,573,012 )
Cash and cash equivalents, beginning of the period 1,673,072     3,721,765  
Cash and cash equivalents, end of the period $ 1,202,334     $ 2,148,753  
       
Supplemental disclosures of cash flows information:      
Cash paid for interest $ —     $ 31,150  
Exchange of stock for non-controlling interest in Ilios $ —     $ 330,852  

(1) Non-GAAP Financial Measures
In addition to reporting net income, a U.S. generally accepted accounting principle (“GAAP”) measure, this news release contains information about EBITDA (net income attributable to Tecogen Inc adjusted for interest, depreciation and amortization, stock based compensation expense, unrealized loss on investment securities and merger related expenses), which is a non-GAAP measure.  The Company believes EBITDA allows investors to view its performance in a manner similar to the methods used by management and provides additional insight into its operating results.  EBITDA is not calculated through the application of GAAP.  Accordingly, it should not be considered as a substitute for the GAAP measure of net income and, therefore, should not be used in isolation of, but in conjunction with, the GAAP measure.  The use of any non-GAAP measure may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 4

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 2

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 2

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading

Top 5 Most Recently Viewed Articles

New Terminal One at JFK Seeks Partners for Enhanced Services

Updated Category News Views 350

Transforming Guest Experiences at JFK Airport The New Terminal One at JFK has initiated a significant step in enhancing the overall travel experience for passengers by announcing two new Requests for Proposals (RFPs). One is aimed at securing a provider for Guest Experience Services while the other focuses on Passengers Requiring Assistance (PRA) Services. These...

Continue Reading
PRN Strengthens Leadership with Key Promotions and New Hire

Updated Category News Views 198

Physical Rehabilitation Network Welcomes New Leadership Changes Physical Rehabilitation Network (PRN) is making significant strides in enhancing its leadership team with recent key promotions and a new appointment. This dynamic move is designed not only to support the continual growth of PRN, but also to ensure that the organization maintains its dedication to delivering...

Continue Reading
Callan JMB Shares Financial Highlights and Future Outlook

Updated Category News Views 324

Callan JMB Financial Results and Business Progress Callan JMB INC. (NASDAQ: CJMB), a dynamic force in integrative logistics, has recently shared its comprehensive financial results for the full year ending in 2024 while also offering an enlightening business update. This Texas-based company plays a crucial role in empowering the healthcare sector and emergency management...

Continue Reading
Bitcoin Approaches $100K: What Investors Should Know Now

Updated Category News Views 135

Bitcoin Price Surge Continues Amid Optimistic Sentiment Bitcoin has been on an impressive rally, recently reaching a notable price of $97,003.4. This surge reflects a positive sentiment within the cryptocurrency community, as investors remain optimistic about Bitcoin's potential despite broader market concerns. The cryptocurrency market has witnessed a substantial spike...

Continue Reading
Herbal Supplements for Liver Health Gain Ground

Updated Category News Views 51

Riding the Herbal Wave for Liver Health In the ever-shifting world of wellness, there's a hot ticket on the rise: herbal supplements for liver health. Look around and you'll notice that natural remedies are becoming the go-to for folks who want to keep their liver in top shape. It's like suddenly everyone woke up to the idea that maybe our ancestors knew a thing or two...

Continue Reading